Your browser doesn't support javascript.
Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol.
Sablerolles, Roos S G; Goorhuis, Abraham; GeurtsvanKessel, Corine H; de Vries, Rory D; Huckriede, Anke L W; Koopmans, Marion P G; Lafeber, Melvin; Postma, Douwe F; van Baarle, Debbie; Visser, Leo G; Dalm, Virgil A S H; Kootstra, Neeltje A; Rietdijk, Wim J R; van der Kuy, P Hugo M.
  • Sablerolles RSG; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
  • Goorhuis A; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, Netherlands.
  • GeurtsvanKessel CH; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Amsterdam, Netherlands.
  • de Vries RD; Infection & Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, Netherlands.
  • Huckriede ALW; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.
  • Koopmans MPG; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.
  • Lafeber M; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
  • Postma DF; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.
  • van Baarle D; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
  • Visser LG; Department of Internal Medicine, University Medical Center Groningen, Groningen, Netherlands.
  • Dalm VASH; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
  • Kootstra NA; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
  • Rietdijk WJR; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
  • van der Kuy PHM; Department of Internal Medicine, Division of Allergy & Clinical Immunology and Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands.
Front Immunol ; 12: 753319, 2021.
Article in English | MEDLINE | ID: covidwho-1485057
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Front Immunol Year: 2021 Document Type: Article Affiliation country: Fimmu.2021.753319

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Front Immunol Year: 2021 Document Type: Article Affiliation country: Fimmu.2021.753319